Prop 65 Supplements Readiness: California Warnings, Lead Threshold Reality and the Bounty-Hunter Enforcement Model
California Proposition 65 — the Safe Drinking Water and Toxic Enforcement Act of 1986 — requires any product sold in California to carry a clear and reasonable warning if it can expose a consumer to a listed chemical above a defined safe-harbour threshold. For dietary supplements the dominant risks are lead and other heavy metals in botanical and mineral ingredients, plus a long-tail list of pesticide residues, polycyclic aromatic hydrocarbons (PAHs) from drying processes, and naturally occurring contaminants. Prop 65 is enforced by the California Attorney General, district attorneys, city attorneys — and, uniquely, by private 'bounty hunter' plaintiffs who can sue under the citizen suit provision and keep 25% of the civil penalties. Settlement-driven litigation against supplement brands is a defining commercial risk in the US market. This guide maps the regime and the operating posture that defends against it.
The regime — listed chemicals, exposure thresholds and the warning duty
Lead in supplements — the threshold that drives most settlements
The warning — short-form, long-form and the digital-channel rules
The bounty-hunter enforcement model — and why it matters more than the AG
An operating posture that defends against Prop 65 risk
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Frequently asked
Does Prop 65 apply if I am not based in California?
Can I just put a Prop 65 warning on everything to be safe?
What is the MADL for lead and why does it catch so many supplements?
What happens when a Notice of Violation arrives?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
